Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04508777 · ClinicalTrials.gov registry record
COVID SAFE: COVID-19 Screening Assessment for Exposure
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 1,759
- Enrollment target
NCT04508777: Completed study, sponsored by University of Pennsylvania.
NCT04508777 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 1,759 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04508777 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 1,759 participants
- Enrollment target
Study Summary
In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. This study will evaluate the implementation of a COVID-19 screening program that coordinates several existing systems at the University of Pennsylvania including saliva-based viral testing.
Interventions
- BEHAVIORAL Saliva-based testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,759 participants |
| Start Date | 2020-09-09 |
| Est. Completion | 2021-06-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04508777
The ClinicalTrials.gov registry entry for NCT04508777 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,759 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Saliva-based testing is the first listed.
NCT04508777 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04508777 about?
NCT04508777 is a clinical study titled "COVID SAFE: COVID-19 Screening Assessment for Exposure". In order to safely and effectively reopen businesses and universities across the US, institutions will need to develop approaches to rapidly identify COVID-19 cases and manage their spread while balancing program effectiveness, feasibility, costs, and scalability. This study will evaluate the imple...
What is the current status of trial NCT04508777?
This trial is currently completed. The enrollment target is 1,759 participants. The study started on 2020-09-09. Estimated completion is 2021-06-23.
What interventions are being tested in trial NCT04508777?
The interventions under investigation include: Saliva-based testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04508777?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.